Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Peptides

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.peptides.2015.07.023PMID 26238597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inactivation of the Antifungal and Immunomodulatory Properties of Human Cathelicidin LL-37 by Aspartic Proteases Produced by the Pathogenic Yeast Candida albicans

  2015cited by this paper
• Mini-review: Antimicrobial peptides and enzymes as promising candidates to functionalize biomaterial surfaces

  2014cited by this paper
• UK Standards for Microbiology Investigations

  2014cited by this paper
• Identification of antimicrobial peptides and immobilization strategy suitable for a covalent surface coating with biocompatible properties.

  2014cited by this paper
• Site specific immobilization of a potent antimicrobial peptide onto silicone catheters: evaluation against urinary tract infection pathogens.

  2014cited by this paper
• Interplay between Candida albicans and the Antimicrobial Peptide Armory

  2014cited by this paper
• Antimicrobial functionalization of silicone surfaces with engineered short peptides having broad spectrum antimicrobial and salt-resistant properties.

  2014cited by this paper
• Derivatives of the Mouse Cathelicidin-Related Antimicrobial Peptide (CRAMP) Inhibit Fungal and Bacterial Biofilm Formation

  2014cited by this paper
• Fungicidal Mechanisms of Cathelicidins LL-37 and CATH-2 Revealed by Live-Cell Imaging

  2014cited by this paper
• Human Cathelicidin Production by the Cervix

  2014cited by this paper
• Antimicrobial host defence peptide, LL-37, as a potential vaginal contraceptive.

  2014cited by this paper
• Antifungal Susceptibility Patterns, In Vitro Production of Virulence Factors, and Evaluation of Diagnostic Modalities for the Speciation of Pathogenic Candida from Blood Stream Infections and Vulvovaginal Candidiasis

  2014cited by this paper
• Antimicrobial peptides stage a comeback

  2013cited by this paper
• Genomewide screening for genes involved in biofilm formation and miconazole susceptibility in Saccharomyces cerevisiae.

  2013cited by this paper
• Recent insights into Candida albicans biofilm resistance mechanisms

  2013cited by this paper
• Fungal Morphogenetic Pathways Are Required for the Hallmark Inflammatory Response during Candida albicans Vaginitis

  2013cited by this paper
• Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United States: Results From an Internet Panel Survey

  2013cited by this paper
• Antifungal Activity of the Noncytotoxic Human Peptide Hepcidin 20 against Fluconazole-Resistant Candida glabrata in Human Vaginal Fluid

  2013cited by this paper
• LL37 and hBD-3 elevate the β-1,3-exoglucanase activity of Candida albicans Xog1p, resulting in reduced fungal adhesion to plastic.

  2012cited by this paper
• A comprehensive summary of LL-37, the factotum human cathelicidin peptide.

  2012cited by this paper
• Amphotericin primarily kills yeast by simply binding ergosterol

  2012cited by this paper
• Comparative activity and mechanism of action of three types of bovine antimicrobial peptides against pathogenic Prototheca spp.

  2012cited by this paper
• The effect of biomaterials and antifungals on biofilm formation by Candida species: a review

  2012cited by this paper
• Antifungal susceptibility of Candida albicans in biofilms

  2012cited by this paper
• Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics.

  2012cited by this paper
• Modulation of cytokine gene expression by cathelicidin BMAP-28 in LPS-stimulated and -unstimulated macrophages.

  2012cited by this paper
• Fungal Biofilm Resistance

  2012cited by this paper
• Human Antimicrobial Peptide LL-37 Inhibits Adhesion of Candida albicans by Interacting with Yeast Cell-Wall Carbohydrates

  2011cited by this paper
• Recurrent vulvovaginal candidosis: focus on the vulva

  2011cited by this paper
• Stability, toxicity, and biological activity of host defense peptide BMAP28 and its inversed and retro‐inversed isomers

  2011cited by this paper
• Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs.

  2011cited by this paper
• Antimicrobial peptides: Old Molecules with New Ideas

  2011cited by this paper
• Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients.

  2011cited by this paper
• Use of antimicrobial peptides against microbial biofilms: advantages and limits.

  2011cited by this paper
• Multifunctional cationic host defence peptides and their clinical applications

  2011cited by this paper
• Cyclodextrin-functionalized biomaterials loaded with miconazole prevent Candida albicans biofilm formation in vitro.

  2010cited by this paper
• Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis.

  2010cited by this paper
• Fungicidal activity of miconazole against Candida spp. biofilms.

  2010cited by this paper
• Broad-Spectrum Activity against Bacterial Mastitis Pathogens and Activation of Mammary Epithelial Cells Support a Protective Role of Neutrophil Cathelicidins in Bovine Mastitis

  2010cited by this paper
• Candida albicans forms biofilms on the vaginal mucosa

  2010cited by this paper
• Inhibition of Candida albicans Biofilm Formation by Antimycotics Released from Modified Polydimethyl Siloxane

  2010cited by this paper
• Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases

  2010cited by this paper
• Candida Infections of the Genitourinary Tract

  2010cited by this paper
• Scanning Electron and Confocal Scanning Laser Microscopy Imaging of the Ultrastructure and Viability of Vaginal Candida albicans and Non-Albicans Species Adhered to an Intrauterine Contraceptive Device

  2010cited by this paper
• Uropathogenic Escherichia coli Modulates Immune Responses and Its Curli Fimbriae Interact with the Antimicrobial Peptide LL-37

  2010cited by this paper
• Interaction of Candida albicans Biofilms with Antifungals: Transcriptional Response and Binding of Antifungals to Beta-Glucans

  2010cited by this paper
• Biofilm formation in clinical Candida isolates and its association with virulence.

  2009cited by this paper
• Structure-function study of cathelicidin-derived bovine antimicrobial peptide BMAP-28: design of its cell-selective analogs by amino acid substitutions in the heptad repeat sequences.

  2009cited by this paper
• Killing of Trypanosomatid Parasites by a Modified Bovine Host Defense Peptide, BMAP-18

  2009cited by this paper
• Primate cathelicidin orthologues display different structures and membrane interactions.

  2009cited by this paper
• Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition

  2009cited by this paper
• Screening and characterization of surface-tethered cationic peptides for antimicrobial activity.

  2009cited by this paper
• Candida albicans biofilm formation on peptide functionalized polydimethylsiloxane

  2009cited by this paper
• EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)∗

  2008cited by this paper
• Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation

  2008cited by this paper
• The Human Cathelicidin LL-37 Modulates the Activities of the P2X7 Receptor in a Structure-dependent Manner*

  2008cited by this paper
• The Cell Wall of the Human Pathogen Candida glabrata: Differential Incorporation of Novel Adhesin-Like Wall Proteins

  2008cited by this paper
• Can intrauterine contraceptive devices be a Candida albicans reservoir?

  2008cited by this paper
• Vulvovaginal candidosis.

  2007cited by this paper
• Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.

  2007cited by this paper
• Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

  2006cited by this paper
• Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance

  2006cited by this paper
• Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts.

  2006cited by this paper
• Alpha-helical antimicrobial peptides--using a sequence template to guide structure-activity relationship studies.

  2006cited by this paper
• Human β-Defensins Kill Candida albicans in an Energy-Dependent and Salt-Sensitive Manner without Causing Membrane Disruption

  2006cited by this paper
• Azoles: mode of antifungal action and resistance development. Effect of miconazole on endogenous reactive oxygen species production in Candida albicans

  2006cited by this paper
• Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane.

  2005cited by this paper
• Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection.

  2005cited by this paper
• Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins

  2005cited by this paper
• Alternative Candida albicans lifestyles: growth on surfaces.

  2005cited by this paper
• The role of cathelicidins in the innate host defenses of mammals.

  2005cited by this paper
• Mammalian defensins in the antimicrobial immune response

  2005cited by this paper
• Cathelicidins, multifunctional peptides of the innate immunity

  2004cited by this paper
• Human β-Defensins 2 and 3 Demonstrate Strain-Selective Activity against Oral Microorganisms

  2004cited by this paper
• Candida Infections of Medical Devices

  2004cited by this paper
• In vitro and in vivo antimicrobial activity of two α-helical cathelicidin peptides and of their synthetic analogs

  2003cited by this paper
• MUC7 20-Mer: Investigation of Antimicrobial Activity, Secondary Structure, and Possible Mechanism of Antifungal Action

  2003cited by this paper
• Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols

  2003cited by this paper
• Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

  2002cited by this paper
• Antimicrobial peptides of multicellular organisms

  2002cited by this paper
• Mode of action of membrane active antimicrobial peptides.

  2002cited by this paper
• Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicansBiofilms

  2001cited by this paper
• A vaginal fluid simulant.

  1999cited by this paper
• The Human Cationic Antimicrobial Protein (hCAP18), a Peptide Antibiotic, Is Widely Expressed in Human Squamous Epithelia and Colocalizes with Interleukin-6

  1999cited by this paper
• Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37*

  1998cited by this paper
• Apolipoprotein A-I Binds and Inhibits the Human Antibacterial/Cytotoxic Peptide LL-37*

  1998cited by this paper
• Biological Characterization of Two Novel Cathelicidin-derived Peptides and Identification of Structural Requirements for Their Antimicrobial and Cell Lytic Activities*

  1996cited by this paper
• Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations.

  1988cited by this paper

• Enhanced anti-Candida activity and mode of action of JII-R1, a jelleine-II peptide derivative of royal jelly origin

  2025cites this paper
• Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis

  2025cites this paper
• Natural Human Antimicrobial Peptides and Female Reproductive Tract Infections

  2025cites this paper
• Current status of antimicrobial peptides databases and computational tools for optimization

  2025cites this paper
• The Contribution of Human Antimicrobial Peptides to Fungi

  2025cites this paper
• Emerging Trends in Hydrogels for the Treatment of Vaginal Candidiasis: A Comprehensive Review.

  2025cites this paper
• Artificial intelligence using a latent diffusion model enables the generation of diverse and potent antimicrobial peptides

  2025cites this paper
• Novel Strategies for Preventing Fungal Infections—Outline

  2025cites this paper
• Antimicrobial activity of a decapeptide against Candida albicans

  2025cites this paper
• Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats.

  2025cites this paper
• Antifungal peptides from living organisms

  2024cites this paper
• Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis

  2024cites this paper
• Exploring the frontiers of therapeutic breadth of antifungal peptides: A new avenue in antifungal drugs

  2024cites this paper
• Mechanistic insights on the antibacterial action of the kyotorphin peptide derivatives revealed by in vitro studies and Galleria mellonella proteomic analysis.

  2024cites this paper
• In Vitro and In Vivo Anti-Candida albicans Activity of a Scorpion-Derived Peptide

  2024cites this paper
• Heterologous Production of Antimicrobial Peptides: Notes to Consider

  2024cites this paper
• Tryptophan End-Tagging Confers Antifungal Activity on a Tick-Derived Peptide by Triggering Reactive Oxygen Species Production

  2024cites this paper
• Antifungal properties of cathelicidin LL-37: current knowledge and future research directions

  2023influential citation
• Exploring therapeutic avenues: mesenchymal stem/stromal cells and exosomes in confronting enigmatic biofilm-producing fungi

  2023cites this paper
• Antimicrobial approaches for medical implants coating to prevent implants associated infections: Insights to develop durable antimicrobial implants

  2023cites this paper
• In vitro and in vivo Activity of Phibilin Against Candida albicans

  2022cites this paper
• Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species

  2022cites this paper
• ANTIFUNGAL AND ANTIOXIDANT PEPTIDES FROM OIL PALM MESOCARPS

  2022cites this paper
• Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in Candida auris

  2022cites this paper
• Hexyl-Aminolevulinate Ethosomes: a Novel Antibiofilm Agent Targeting Zinc Homeostasis in Candida albicans

  2022cites this paper
• Antimicrobial Peptides—Mechanisms of Action, Antimicrobial Effects and Clinical Applications

  2022cites this paper
• Antimicrobial Peptides with Anti-Candida Activity

  2022cites this paper
• Anti-fungal Effects and Mechanisms of Action of Wasp Venom-Derived Peptide Mastoparan-VT1 Against Candida albicans

  2022cites this paper
• Antimicrobial Peptides: The Promising Therapeutics for Cutaneous Wound Healing.

  2021cites this paper
• Anticandidal Activity of Omiganan and Its Retro Analog Alone and in Combination with Fluconazole

  2021cites this paper
• Membrane-Interacting Antifungal Peptides

  2021cites this paper
• Antifungal Activity of Linear and Disulfide-Cyclized Ultrashort Cationic Lipopeptides Alone and in Combination with Fluconazole against Vulvovaginal Candida spp.

  2021cites this paper
• Therapeutic Effect of an Antibody-Derived Peptide in a Galleria mellonella Model of Systemic Candidiasis

  2021cites this paper
• Antifungal and anti-biofilm activity of designed derivatives from kyotorphin.

  2020cites this paper
• Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response

  2020cites this paper
• Targeting Biofilms Therapy: Current Research Strategies and Development Hurdles

  2020cites this paper
• Vaginitis: Review on drug resistance.

  2020cites this paper
• Combined effect of lasioglossin LL-III derivative with azoles against Candida albicans virulence factors: biofilm formation, phospholipases, proteases, and hemolytic activity.

  2020cites this paper
• Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds

  2020cites this paper
• Bioactive Peptides Against Fungal Biofilms

  2019cites this paper
• Bio-active Peptides: Role in Plant Growth and Defense

  2019cites this paper
• AMPs as Anti-biofilm Agents for Human Therapy and Prophylaxis.

  2019cites this paper
• Rhamnolipid inspired lipopeptides effective in preventing adhesion and biofilm formation of Candida albicans.

  2019cites this paper
• Anti-biofilm Peptides: A New Class of Quorum Quenchers and Their Prospective Therapeutic Applications

  2018cites this paper
• Unexplored antifungal activity of linear battacin lipopeptides against planktonic and mature biofilms of C. albicans.

  2018cites this paper
• Antifungal activity of spider venom-derived peptide lycosin-I against Candida tropicalis.

  2018cites this paper
• Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: One species, four names

  2018cites this paper
• Effective inhibition of Cbf-14 against Cryptococcus neoformans infection in mice and its related anti-inflammatory activity.

  2018cites this paper
• Biotechnological Applications of Quorum Sensing Inhibitors

  2018cites this paper
• Antibacterial Effect of Synthetic Peptide LyeTxI and LyeTxI/&bgr;‐Cyclodextrin Association Compound Against Planktonic and Multispecies Biofilms of Periodontal Pathogens

  2017cites this paper
• Is cathelicidin a novel marker of diabetic microangiopathy in patients with type 1 diabetes?

  2017cites this paper
• Approaches to Dispersing Medical Biofilms

  2017cites this paper
• Perspectives for clinical use of engineered human host defense antimicrobial peptides

  2017cites this paper
• Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi

  2017cites this paper
• Natural and synthetic peptides with antifungal activity.

  2016cites this paper
• Antifungal peptides: To be or not to be membrane active.

  2016cites this paper
• Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida

  2016cites this paper
• Cathelicidin (LL‐37) level in the scalp hair of patients with tinea capitis

  2016cites this paper
• Chlorin e6-mediated photodynamic inactivation with halogen light against microbes and fungus

  2015cites this paper